John Cox, Director at REPLIGEN CORP (RGEN), sold 8,810 shares at $92.76 ($817K) on 2020-02-24, disclosed to the SEC on 2020-02-26.
Open-market sale of $817k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.76 | 4,355 | $404K | 49.4% |
| 2 | $92.76 | 4,355 | $404K | 49.4% |
| 3 | $94.85 | 100 | $9K | 1.2% |
| Total | $92.78 avg | 8,810 | $817K | 100% |
| Filing → |
| DYN | SELL | 2026-06-17 | $49K | — | Filing → |
| DYN | SELL | 2026-05-14 | $61K | — | Filing → |
| DYN | SELL | 2026-03-06 | $41K | — | Filing → |